In vitro interactions between the oral absorption promoter, sodium caprate (C10) and S. typhimurium in rat intestinal ileal mucosae

Pharmaceutical Research

Volumn 25, Issue 1, 2008, Pages 114-122

  Cox, Alyssa B ^a   Rawlinson, Lee Anne ^a   Baird, Alan W ^a   Bzik, Victoria ^a   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

C10; Intestinal bacterial adhesion; Medium chain fatty acids; Oral peptide delivery; Ussing chamber

Indexed keywords

CARBON 14; DECANOATE SODIUM; MANNITOL; MEDIUM CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIUM ADHERENCE; CONTROLLED STUDY; DIFFUSION CHAMBER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HISTOLOGY; ILEUM MUCOSA; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM;

ANIMALS; BACTERIAL ADHESION; DECANOIC ACIDS; DIFFUSION CHAMBERS, CULTURE; EXCIPIENTS; FLUORESCENT DYES; ILEUM; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MALE; MANNITOL; RATS; SALMONELLA TYPHIMURIUM;

EID: 38049144195     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9354-9     Document Type: Article

References (49)

1. R. J. Mrsny. Modification of epithelial tight junction integrity to enhance transmucosal absorption. Crit. Rev. Ther. Drug Carr. Syst. 22:331-418 (2005).
2. H. Han, R. L. de Vrueh, J. K. Rhie, K. M. Covitz, P. L. Smith, C. P. Lee, D. M. Oh, W. Sadee, and G. L. Amidon. 5′-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm. Res. 15:1154-1159 (1998).
3. M. A. Miller, N. B. Malkar, D. Severeynse-Stevens, K. G. Yarbrough, M. J. Bednarcik, R. E. Dugdell, M. E. Puskas, R. Krishnan, and K. D. James. Amphiphilic conjugates of human brain natriuretic peptide designed for oral delivery: in vitro activity screening. Bioconjug. Chem. 17:267-274 (2006).
4. S. A. Galindo-Rodriguez, E. Allemann, H. Fessi, and E. Doelker. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit. Rev. Ther. Drug Carr. Syst. 22:419-464 (2005).
5. A. des Rieux, V. Fievez, M. Garinot, Y.-J. Schneider, and V. Preat. Nanoparticles as potential delivery systems of proteins and vaccines. J. Control. Release 116:1-27 (2006).
6. T. Lindmark, T. Nikkila, and P. Artursson. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J. Pharm. Exp. Ther. 275:958-964 (1995).
7. N. A. Motlekar, A. Fasano, M. S, Wachtel, and B. B. Youan. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin. J. Drug Target 14:321-329 (2006).
8. C. Prego, M. Fabre, D. Torres, and M. J. Alonso. Efficacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm. Res. 23:549-556 (2006).
9. J. D. Soderholm, H. Oman, L. Blomquist, J. Veen, T. Lindmark, and G. Olaisin. Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat. Dig. Dis. Sci. 43:1547-1552 (1998).
10. A. C. Chao, J. V. Nguyen, M. Broughall, A. Griffin, J. A. Fix, and P. E. Daddona. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology. Int. J. Pharm. 191:15-24 (1999).
11. A. A. Raoof, Z. Ramtoola, B. McKenna, R. Z. Yu, G. Hardee, and R. S. Geary. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs. Eur. J. Pharm. Sci. 17:131-138 (2002).
12. H. Lennernas, K. Gjellan, R. Hallgren, and C. Graffner. The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans. J. Pharm. Pharmacol. 54:499-508 (2002).
13. T. W. Leonard, J. Lynch, M. McKenna, and D. J. Brayden. Promoting absorption of drugs in humans using medium-chain fatty acid-based solid dosage forms: GIPET. Expert Opin. Drug Deliv. 3:685-692 (2006).
14. A. A. Raoof, P. Chiu, Z. Ramtoola, I. J. Cumming, C. Teng, S. P. Weinback, G. E. Hardee, A. A. Levin, and R. S. Geary. Oral bioavailability and multiple dose tolerability of an antisense oligonucleotide tablet formulated with sodium caprate. J. Pharm. Sci. 93:1431-1439 (2004).
15. E. K. Anderberg, T. Lindmark, and P. Artursson. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route. Pharm. Res. 10:857-864 (1993).
16. T. Lindmark, Y. Kimura, and P. Artursson. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J. Pharm. Exp. Ther. 284:362-369 (1998).
17. T. Lindmark, J. D. Soderholm, G. Olaison, G. Alvan, G. Ocklind, and P. Artursson. Mechanism of absorption enhancement in humans after rectal administration of ampicillin in suppositories containing sodium caprate. Pharm. Res. 14:930-935 (1997).
18. Y. S. Quan, K. Hattori, E. Lundborg, T. Fujita, M. Murakami, S. Muranishi, and A. Yamamoto. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers. Biol. Pharm. Bull. 21:615-620 (1998).
19. N. A. Motlekar, K. S. Srivnugopal, M. S. Watchel, and B. B. Youan. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels. J. Drug Target. 13:573-583 (2005).
20. L. G. Johnson, M. K. Vanhook, C. B. Coyne, N. Haykal-Coates, and S. H. Gavette. Safety and efficiency of modulating paracellular permeability to enhance airway epithelial gene transfer in vivo. Hum. Gene Ther. 14:729-747 (2003).
21. P. Sharma, M. V. Varma, H. P. Shawla, and R. Panchagnula. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Farmaco 60:874-883 (2005).
22. C. B. Coyne, M. M. Kelly, R. C. Boucher, and L. G. Johnson. Enhanced epithelial gene transfer by modulation of tight junctions with sodium caprate. Am. J. Respir. Cell Mol. Biol. 23:602-609 (2000).
23. A. Haque, F. Bowe, R. J. Fitzhenry, G. Frankel, M. Thomson, R. Heuschkel, S. Murch, M. P. Stevens, T. S. Wallis, A. D. Phillips, and G. Dougan. Early interactions of Salmonella enterica serovar typhimurium with human small intestinal epithelial explants. Gut 53:1424-1430 (2004).
24. P. S. Mead, L. Slutsker, V. Dietz, L. F. McCaig, J. S. Bresee, C. Shapiro, P. M. Griffin, and R. V. Tauxe. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625 (1999).
25. C. Tukel, M. Raffatellu, D. Chessa, R. P. Wilson, M. Akcelik, and A. J. Baumler. Neutrophil influx during non-typhoidal salmonellosis: who is in the driver's seat? FEMS Immunol. Med. Microbiol. 46:320-329 (2006).
26. J. Soni, A. W. Baird, L. M. O'Brien, M. McElroy, J. J. Callanan, H. F. Bassett, D. Campion, and D. J. Brayden. Rat, ovine and bovine Peyer's patches mounted in horizontal diffusion chambers display sampling function. J. Control. Release 115:68-77 (2006).
27. M. Leonard, E. Creed, D. Brayden, and A. W. Baird. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport. Pharm. Res. 17:1181-1188 (2000).
28. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-seventh edition. CLSI document M7-A7 (ISBM 1-56238-587-9). Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2006.
29. G. L. French. Bactericidal agents in the treatment of MRSA infections-the potential role of daptomycin. J. Antimicrob. Chemother. 58:1107-1117 (2006).
30. National Committee for Clinical Laboratory Standards Protocols (NCCLS). Methods for determining bactericidal activity of antimicrobial agents. Approved guideline. NCCLS document M26-A. NCCLS, PA, USA, 1999.
31. I. I. Amin, G. R. Douce, M. P. Osborne, and J. Stephen. Quantitative studies of invasion of rabbit ileal mucosa by Salmonella typhimurium strains which differ in virulence in a model of gastroenteritis. Infect. Immun. 62:569-578 (1994).
32. M. E. Appleyard, and A. D. Smith. Secretion of acetylcholinesterase and butyrylcholinesterase from the guinea-pig isolated ileum. Br. J. Pharmacol. 97:490-498 (1989).
33. M. Sakai, T. Imai, H. Ohtake, and M. Otagiri. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers. J. Pharm. Pharmacol. 50:1101-1108 (1998).
34. S. Takatsuka, T. Morita, A. Koguchi, Y. Horikiri, H. Yamahara, and H. Yoshino. Synergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactant. Int. J. Pharm. 316:124-130 (2006).
35. J. Karlsson, A. Ungell, J. Grajco, and P. Artursson. Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux. Eur. J. Pharm. Sci. 9:47-56 (1999).
36. N. Jezyk, W. Rubas, and G. M. Grass. Permeability characteristics of various intestinal regions of rabbit, dog, and monkey. Pharm. Res. 9:1580-1586 (1992).
37. A. Collett, D. Walker, E. Sims, Y. L. He, P. Speers, J. Ayrton, M. Rowland, and G. Warhurst. Influence of morphometric factors on quantitation of paracellular permeability of intestinal epithelia in vitro. Pharm. Res. 14:767-773 (1997).
38. T. Namani, and P. Walde. From decanoate micelles to decanoic acid/dodecylbenzenesulfonate vesicles. Langmuir 21:6210-6219 (2005).
39. I. I. Amin, G. R. Douce, M. P. Osborne, and J. Stephen. Quantitative studies of invasion of rabbit ileal mucosa by Salmonella typhimurium strains which differ in virulence in a model of gastroenteritis. Infect. Immun. 62:569-578 (1994).
40. B. D. Jones, S. Ghori, and S. Falkow. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J. Exp. Med. 180:15-23 (1994).
41. S. K. Hops, D. K. Lowe, W. M. Bement, and A. W. West. Migration of Salmonella typhi through intestinal epithelial monolayers: an in vitro study. Microbiol. Immunol. 40:799-811 (1996).
42. S. A. Nakai, and K. J. Siebert. Validation of bacterial growth inhibition models based on molecular properties of organic acids. Int. J. Food Microbiol. 2678:1-7 (2002).
43. B. W. Petschow, R. P. Batema, and L. L. Ford. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob. Agents Chemother. 40:302-306 (1996).
44. F. Van Immerseel, J. De Buck, F. Boyen, L. Bohez, F. Basmans, J. Volf, M. Sevcik, I. Rychlik, F. Haesebrouck, and R. Ducatelle. Medium-chain fatty acids decrease colonization and invasion through hilA suppression shortly after infection of chickens with Salmonella enterica serovar Enteritidis. Appl. Environ. Microbiol. 70:3582-3587 (2004).
45. B. W. Petschow, R. P. Batema, R. D. Talbott, and L. L. Ford. Impact of medium-chain monoglycerides on intestinal colonisation by Vibrio cholerae or enterotoxigenic Escherichia coli. J. Med. Microbiol. 47:383-389 (1998).
46. J. A. Haagensen, M. Clausen, R. K. Ernst, S. I. Miller, A. Folkesson, T. Tolker-Neilson, and S. Molin. Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms. J. Bacteriol. 189:28-37 (2007).
47. B. A. Kumar, M. C. Varadaraj, and R. N. Tharanathan. Low molecular weight chitosan-preparation with the aid of pepsin, characterization, and its bactericidal activity. Biomacromolecules 8:566-572 (2007).
48. S. Keely, S. Carrington, D. M. Haddleton, and D. J. Brayden. An in vitro mucus-secreting intestinal cell model for screening antibiotic effects of polymers. Proc. Int. Symp. Control. Release Bioact. Mater. 33:A295 (2005).
49. S. Maher, L. Feighery, D. J. Brayden, and S. McClean. Melittin as a permeability enhancer II: In vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae. Pharm. Res. 10.1007/s11095-007- 9246-z (2007). In press.